ArticleFrontiers in surgery2024

Postoperative adjuvant immunotherapy and molecular targeted therapy for patients of hepatocellular carcinoma with portal vein tumor thrombus after hepatectomy: a propensity score matching study.

Jiangmin Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.